ARCHIVES

Response From Center Representatives In L.A. To NCI Questions Is “Frusterating,” DeVita Says

This article is from The Cancer Letter archive.

Vol. 10 No. 15 | April 13, 1984

Download PDF Visit The Full Archive

Related Articles

Does a B from USPSTF Guarantee Coverage? Lung Screening will Define Medicare Stance

March 21, 2014

Six Years into The Drug Shortage, And The Causes Are Still a Mystery

October 14, 2011

Executive Summary of Centers, SPOREs Report

February 28, 2003

FDA Advisors Debate Ban, Black Box And Status Quo of Power Morcellators

July 25, 2014

Funding Opportunities: RFAs Available: NCI Challenge For Tumor Classification

February 5, 1999

Benefit Seen In Novel Drug That Treats Gleevec Resistance

April 29, 2005